TY - JOUR
T1 - In vivo and in vitro imaging of I2 imidazoline receptors in the monkey brain
AU - Kawamura, Kazunori
AU - Maeda, Jun
AU - Hatori, Akiko
AU - Okauchi, Takashi
AU - Nagai, Yuji
AU - Higuchi, Makoto
AU - Suhara, Tetsuya
AU - Fukumura, Toshimitsu
AU - Zhang, Ming Rong
PY - 2011/5
Y1 - 2011/5
N2 - I2 imidazoline receptors (I2Rs) are associated with depression, Alzheimer's disease, and Huntington's disease. However, in vivo imaging of I2Rs in the monkey brain has not been reported until now. We performed in vitro and in vivo imaging of (I2Rs) in the monkey brain using 11C-labeled 2-(3-fluoro-4-tolyl)-4,5-dihydro-1H-imidazole ([11C]FTIMD) which has high and selective affinity of I2Rs. In an auto-radiography (ARG) study, the distribution pattern of [11C]FTIMD in the monkey brain was similar to that of [3H]idazoxan binging to I2Rs in the human brain, which was previously described. The specific binding of [11C]FTIMD accounted for >97% of total binding in brain regions existing I2Rs. In positron emission tomography (PET) studies, the radioactivity was accumulated in brain regions existing I2Rs ligand BU224, the accumulated radioactivity was decreased to approximately 66%-75% of the baseline measurement at 15-45 min after injection of [11C]FTIMD. These results suggest that [11C]FTIMD shows the specific-binging to I2Rs in the monkey brain as depicted by PET and ARG. We performed the first in vivo imaging of I2Rs using [11C]FTIMD in the monkey brain. Synapse, 2011. © 2010 Wiley-Liss, Inc.
AB - I2 imidazoline receptors (I2Rs) are associated with depression, Alzheimer's disease, and Huntington's disease. However, in vivo imaging of I2Rs in the monkey brain has not been reported until now. We performed in vitro and in vivo imaging of (I2Rs) in the monkey brain using 11C-labeled 2-(3-fluoro-4-tolyl)-4,5-dihydro-1H-imidazole ([11C]FTIMD) which has high and selective affinity of I2Rs. In an auto-radiography (ARG) study, the distribution pattern of [11C]FTIMD in the monkey brain was similar to that of [3H]idazoxan binging to I2Rs in the human brain, which was previously described. The specific binding of [11C]FTIMD accounted for >97% of total binding in brain regions existing I2Rs. In positron emission tomography (PET) studies, the radioactivity was accumulated in brain regions existing I2Rs ligand BU224, the accumulated radioactivity was decreased to approximately 66%-75% of the baseline measurement at 15-45 min after injection of [11C]FTIMD. These results suggest that [11C]FTIMD shows the specific-binging to I2Rs in the monkey brain as depicted by PET and ARG. We performed the first in vivo imaging of I2Rs using [11C]FTIMD in the monkey brain. Synapse, 2011. © 2010 Wiley-Liss, Inc.
UR - http://www.scopus.com/inward/record.url?scp=79952238488&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952238488&partnerID=8YFLogxK
U2 - 10.1002/syn.20897
DO - 10.1002/syn.20897
M3 - Article
C2 - 21370281
AN - SCOPUS:79952238488
SN - 0887-4476
VL - 65
SP - 452
EP - 455
JO - Synapse
JF - Synapse
IS - 5
ER -